Mcevoy Jw 1

1. 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models
2. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
3. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
4. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases : Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS, the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN, and the European Society of Vascular Medicine (ESVM)
5. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
6. 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
7. 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
8. 2025 ESC Guidelines for the management of myocarditis and pericarditis
9. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10. 2024 ESC Guidelines for the management of chronic coronary syndromes
1